Catholic bishops fear marijuana and freethinking

Florida and South Dakota Catholic bishops applauded the recent defeats of marijuana legalization in their states, something they easily aided and abetted given Florida’s population is 21-percent Catholic and South Dakota’s is 18.4-percent. Protestant factions in the two states also fear and hate cannabis.

The bishops went to the trouble of creating a stack of misinformation about cannabis that likely added to the loss of votes for the ballot proposals:

…marijuana use overstimulates the nervous system while also decreasing high-functioning rational thought.

Often these effects are accompanied by others, including distorted sensory perception or hallucinations, irrational anxiety or panic, diminished motor control and slowed reactions, and reduced learning and memory,” South Dakota’s bishops said. “Studies have shown that impaired cognitive function continues into the workweek even after a person no longer feels intoxicated, and that regular users are at approximately twice the risk of developing psychosis as non-users.” […]

One reason people use and enjoy marijuana is it stimulates high functioning rational and creative thought. It’s not an extraordinary process. Mere daydreaming can create entertaining or useful ideas. And no marijuana smoker has claimed they are latently affected by marijuana well into their work week. Upon cessation the effects of smoking marijuana typically wear off after an hour or so.

Falsehoods are dangerous. People who believe absurdities can go on to commit atrocities. Catholicism and other sects and cults that equate persecution with protection can emerge to survive in ways that require continuous reinforcement of public ignorance. Critical thinking is rejected. Cults engage in mind control techniques designed to prevent their members from using their imaginations, thereby leading to lifelong impaired cognitive functions for their victims. The inquisitions punished improper thinking with burning at the stake. In his 1633 trial Galileo barely escaped with his life. Religious extremists all seem to fear that analyzing or musing about their beliefs and histories will cause their assemblage to collapse.

That is why many religions present themselves as a package deal for people who don’t have time to read the ancient texts in their original languages to produce their own religious viewpoints and experiences. Cult followers like those in Jonestown are expected to swallow their grape Flavor Aid without complaint. South Dakota Governor Kristi Noem, a Protestant who wants to introduce prayer back into public schools was overjoyed when her state’s marijuana initiative failed to pass. She went on to proclaim she never met anyone who got smarter by smoking dope….. Drinking a glass of water doesn’t make anyone smarter either. People do it anyway.

The Catholic Church is famous for their book burning sprees starting in the 9th century. In 1560 it published the Index Librorum Prohibitorum, a list of forbidden books that included medical texts. The Index wasn’t abolished until 1966. In the end all types of literature were purged, along with ancient written records that covered mind expanding cannabis and psilocybin mushrooms. Medical science and progress was replaced with fatalism and a 900-year long Dark Ages that would renew itself in some perverse way if medicine and science is overtaken again by bishops who are anti-marijuana and anti-physics.

This entry was posted in Servetus. Bookmark the permalink.

8 Responses to Catholic bishops fear marijuana and freethinking

  1. Golda says:

    “Falsehoods are dangerous. People who believe absurdities can go on to commit atrocities. Catholicism and other sects and cults that equate persecution with protection can emerge to survive in ways that require continuous reinforcement of public ignorance. Critical thinking is rejected. ”
    Want a current example? You know where to look…

  2. Servetus says:

    Endocannabinoid receptors on interneurons limit stress-induced bad memory generalization to the specific, appropriate memory:

    15-Nov-2024 — Researchers at The Hospital for Sick Children (SickKids) have uncovered that stress changes how our brain encodes and retrieves aversive memories, and discovered a promising new way to restore appropriate memory specificity in people with post-traumatic stress disorder (PTSD). […]

    …stress from traumatic events like violence or generalized anxiety disorder can spread far beyond the original event, known as stress-induced aversive memory generalization, where fireworks or car backfires can trigger seemingly unrelated fearful memories and derail your entire day. In the case of PTSD, it can cause much greater negative consequences. […]

    “A little bit of stress is good, it’s what gets you up in the morning when your alarm goes off, but too much stress can be debilitating,” says Josselyn, who holds a Canada Research Chair in Circuit Basis of Memory. “We know that people with PTSD show fearful responses to safe situations or environments, and have found a way to limit this fearful response to specific situations and potentially reduce the harmful effects of PTSD.”

    Together with their colleague Dr. Matthew Hill at the University of Calgary Hotchkiss Brain Institute, the research team was able to block endocannabinoid receptors on interneurons, and limit stress-induced aversive memory generalization to the specific, appropriate memory. […]

    …the study found that stress caused an increase in the release of endocannabinoids (endogenous cannabinoids) which disrupted the function of interneurons, whose role is it to constrain the size of the engram […]

    The endocannabinoid system enhances memory formation and helps link lived experiences with specific behavioural outcomes. In the amygdala, the emotional processing centre of the brain, certain ‘gate keeper’ interneurons have special receptors for endocannabinoids, and help constrain the size of the engram and the specificity of the memory. But, when too many endocannabinoids are released, the function of the gatekeeping interneurons is disrupted, causing an increase in the size of the engram.

    “Endocannabinoid receptors function like a velvet rope at an exclusive club. When stress induces the release of too many endocannabinoids, the velvet rope falls, causing more generalized aversive fearful memories to form,” explains Josselyn. “By blocking these endocannabinoid receptors just on these specific interneurons, we could essentially prevent one of the most debilitating symptoms of PTSD.” […]

    In 2023, previous research in Science identified larger, more generalized memory engrams in the developing brain than in the adult brain, just like stress-induced memory engrams. As they continue to explore this unexpected link between engram size, stress and age, the teams are also delving into how daily stressors may impact happy memories.

    “The many biological functions and processes that make up the complexity of human memory are still being uncovered,” says Frankland, who holds a Canada Research Chair in Cognitive Neurobiology. “We hope that as we better understand human memory, we can inform real-world therapies for those with various psychiatric and other brain disorders throughout their lifespan.” […]

    AAAS Public Science News Release: How stress is fundamentally changing our memories

    Cell: Stress disrupts engram ensembles in lateral amygdala to generalize threat memory in mice

  3. Let us not forget that Joe Biden, the Landrieu Family, the late Dianne Feinstein, Nancy Pelosi, Harry Connick, Sr.*, Leon Cannizzaro, Jr., John Kerry, Laurie Schlegel, Kathy Edmonston, John Bel Edwards, his two brothers, his wife Donna, Charles Foti, and the St. Martinsville Psycho, Jeff Landry are open Catholics and championed drug prohibition. They also refused to prosecute certain thieves, rapists, and murders on account of being clergy or law enforcement. That isn’t getting into Louisiana’s Protestant establishment, which gave us Edwin Edwards**, Jack Strain, Danny McCormick, Katrina Jones, Woody Jenkins, and Sharon Hewitt. *=Connick died earlier this year, but not behind bars. Colin Heaton did the right thing by dedicating an episode of Most Corrupt to that asshole who threw innocent people in jail while letting violent criminals do as they please.
    **=In addition to being extremely corrupt, Edwards supported the War on Drugs and Mass Incarceration. If that wasn’t enough, he even backed the Reagan Administration’s 1987 plans to build a concentration camp for Arab Americans in Oakdale, LA.

  4. Servetus says:

    An ancient Egyptian mug was found by a USF professor to have once contained hallucinogens:

    15-Nov-2024–A University of South Florida professor found the first-ever physical evidence of hallucinogens in an Egyptian mug, validating written records and centuries-old myths of ancient Egyptian rituals and practices. Through advanced chemical analyses, Davide Tanasi examined one of the world’s few remaining Egyptian Bes mugs.

    Such mugs, including the one donated to the Tampa Museum of Art in 1984, are decorated with the head of Bes, an ancient Egyptian god or guardian demon worshiped for protection, fertility, medicinal healing and magical purification. Published Wednesday in Nature’s Scientific Reports, the study sheds light on an ancient Egyptian mystery: The secret of how Bes mugs were used about 2,000 years ago.

    “There’s no research out there that has ever found what we found in this study,” Tanasi said. “For the first time, we were able to identify all the chemical signatures of the components of the liquid concoction contained in the Tampa Museum of Art’s Bes mug, including the plants used by Egyptians, all of which have psychotropic and medicinal properties.” […]

    With a pulverized sample from scraping the inner walls of the vase, the team combined numerous analytical techniques for the first time to uncover what the mug last held.

    The new tactic was successful and revealed the vase had a cocktail of psychedelic drugs, bodily fluids and alcohol – a combination that Tanasi believes was used in a magical ritual reenacting an Egyptian myth, likely for fertility. The concoction was flavored with honey, sesame seeds, pine nuts, licorice and grapes, which were commonly used to make the beverage look like blood. […]

    “Religion is one of the most fascinating and puzzling aspects of ancient civilizations,” Tanasi said. “With this study, we’ve found scientific proof that the Egyptian myths have some kind of truth and it helps us shed light on the poorly understood rituals that were likely carried out in the Bes Chambers in Saqqara, near the Great Pyramids at Giza.” […]

    View a 3D model of the Bes mug produced by the USF Institute for Digital Exploration.

    AAAS Public Science News Release: USF study confirms Egyptians drank hallucinogenic cocktails in ancient rituals…New paper’s findings reveal a mix of psychedelic drugs, body fluids and alcohol likely used for fertility rituals

    Nature: Multianalytical investigation reveals psychotropic substances in a ptolemaic Egyptian vase

    Authors: Davide Tanasi, Branko F. van Oppen de Ruiter, Fiorella Florian, Radmila Pavlovic, Luca Maria Chiesa, Igor Fochi, Chiaramaria Stani, Lisa Vaccari, Dale Chaput, Giorgio Samorini, Alberto Pallavicini, Sabrina Semeraro, Anastasia Serena Gaetano, Sabina Licen, Pierluigi Barbieri & Enrico Greco.

  5. Servetus says:

    Cannabidiol (CBD) is investigated as a treatment for attention deficit hyperactivity disorder (ADHD):

    25-Nov-2024 – Current medical guidelines for ADHD include medications such as Adderall and cognitive behavioral therapy. As with most treatments, the benefits can be accompanied by downsides. “Parents are interested in cannabidiol, which does not contain THC,” Dr. Ryan says. “But we don’t have the science yet to back recommendations.” […]

    The researchers focused on how cannabis use affects ADHD symptoms. Furthermore, the human body produces its own cannabinoids – the endocannabinoid system – which led the researchers to wonder how might this endogenous system influence ADHD? They scrutinized clinical and preclinical findings, which together suggest that cannabis affects the endocannabinoid system in a variety of ways to affect attention, hyperactivity and anxiety.

    “A relationship is there,” Dr. Ryan says. However, the picture is complicated by the sheer variety of cannabis products used, the many types of endocannabinoids and their biological pathways and the variability of ADHD presentation in people. Teasing all these factors apart, she says, “is super complicated.” In addition, cannabis researchers are hobbled by legal restrictions around marijuana. […]

    Cannabis, maybe, for attention problems–
    how the body’s own cannabinoids may influence the symptoms and treatment of ADHD

    Attention Deficit Hyperactivity Disorder, Cannabis Use, and the Endocannabinoid System: A Scoping Review

    Authors: Jennie E. Ryan, Mitchell Fruchtman, Andrea Sparr-Jaswa, Amy Knehans, Brooke Worster.

  6. Servetus says:

    An evaluation prepared in Germany demonstrates that severe tobacco addiction can be medically treated using nicotine or the drug varenicline:

    27-Nov-2024 – By law, smokers with severe tobacco dependence are entitled to receive one-off drug therapy for smoking cessation as part of evidence-based programmes reimbursed by the German statutory health insurance (SHI). Before deciding which drugs would be eligible, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to assess the benefit of the four currently approved drugs for the treatment of severe tobacco dependence.

    IQWiG has now published its final benefit assessment of bupropion, cytisine, nicotine and varenicline for smoking cessation, also in combination with each other, compared with no drug therapy. According to the findings, there is proof of greater benefit for treatment with nicotine and varenicline: study participants who took one of these drugs for smoking cessation in addition to supportive non-drug interventions were considerably more likely to be smoke-free six months after treatment than those without such additional drug therapy. […]

    Smokers who took varenicline were more likely to be smoke-free after six and twelve months than those without drug therapy. […]

    Nicotine is also an effective smoking cessation drug: smokers who took nicotine for tobacco dependence were more likely to be smoke-free after six months than those who did not. The study participants who took nicotine were also more likely to be smoke-free after twelve months, although the study data for this point in time is not as conclusive as for six months. […]

    AAAS Public Science News Release: Smoking cessation in severe tobacco dependence: benefit proven for two of four drugs — Varenicline and nicotine offer clear advantages for smokers who are severely addicted to tobacco

    There is a lack of corresponding evidence for bupropion and cytisine and for drug combination therapy. English translation of the final report now available.

  7. Servetus says:

    Ayahuasca (DMT) effects on the brain in reducing fear and anxiety are modulated by cross-talk between two serotonin receptor sites:

    RIBEIRÃO PRETO, São Paulo, Brazil, 3 December 2024 – As interest in psychedelic medicine grows, researchers have synthesized a decade of evidence to understand how ayahuasca influences fear and anxiety in the brain. A new review published in Psychedelics consolidates findings from molecular studies, animal research, and human trials to create a clearer picture of how this traditional Amazonian brew affects emotional processing and memory systems.

    The analysis, led by Lorena Terene Lopes Guerra and colleagues at the University of São Paulo, examines the growing body of evidence about ayahuasca’s complex interactions with brain systems involved in emotional processing and memory, with particular focus on its effects through two distinct serotonin receptor systems. […]

    The review synthesizes evidence showing that ayahuasca’s effects involve a delicate balance between two serotonin receptor types: 5-HT2A and 5-HT1A. This dual action appears crucial for understanding both the immediate effects of ayahuasca and its potential long-term therapeutic benefits.

    Key findings from the reviewed literature include:

    • Ayahuasca’s main component, DMT, acts primarily through 5-HT2A receptors to influence emotional processing

    • The brew’s β-carboline compounds may work through different mechanisms to affect memory and anxiety

    • Clinical studies suggest specific effects on fear extinction and emotional processing

    • Brain imaging studies show ayahuasca modulates activity in regions crucial for emotional regulation

    The synthesis of available evidence raises important questions about ayahuasca’s therapeutic potential. Can the timing of ayahuasca administration be optimized for treating specific conditions? Might different preparations of ayahuasca be more effective for different therapeutic purposes? How do individual differences in receptor systems affect treatment outcomes?

    Current evidence reviewed suggests ayahuasca might be particularly promising for treating PTSD and anxiety disorders. However, Dr. dos Santos emphasizes the need for more controlled clinical trials: “While the preclinical and observational evidence is encouraging, we need more rigorous clinical studies to understand the optimal therapeutic applications.” […]

    AAAS Public Science News Release: Scientists map how ayahuasca affects fear circuits in comprehensive review–New analysis synthesizes decade of research on psychedelic brew’s effects on anxiety and trauma responses

    Monograph PDF Genomics Press: https://url.genomicpress.com/2p9dauta

  8. Servetus says:

    Doctors and medical professionals working on the frontlines of the COVID pandemic found significant relief from psilocybin while participating in a study of the effects of psilocybin in reducing depression and despair:

    5-Dec-2024 — Psilocybin therapy helps clinicians process COVID despair–In a novel study of front-line providers, the psychedelic drug reduced symptoms of depression more effectively than a placebo.

    Psilocybin-assisted psychotherapy resulted in significant reductions in depression among clinicians who provided front-line COVID-19 care in 2020 and 2021. These reductions were measurably greater than those experienced by the cohort of clinicians who received a placebo instead. […]

    “For doctors and nurses who feel burned out or disillusioned or disconnected from the patient care they want to provide, this study shows that psilocybin therapy is safe and can help these clinicians work through those feelings and get better,” said Dr. Anthony Back, the lead investigator. […]

    About 2,200 clinicians from across the United States applied for the study’s 30 slots. The participants — all clinicians who met criteria for providing front-line pandemic care — were chosen by lottery. All had seen death and dying at a rate and intensity they had never experienced before, Back said.

    At the study’s outset, the participants were confirmed as having no prepandemic mental health diagnoses but currently experiencing moderate to severe symptoms of depression, as measured by a rating scale. They were then randomized to the psilocybin group or the control group, but without knowing which group.

    Back said the 30 enrollees described being exhausted and experiencing crises of confidence, emotional detachment from patients, withdrawal from loved ones and colleagues, and, for some, doubts about whether their medical career was still viable.

    “Some people who came into the study were really in despair,” he said. “A number of people said, ‘I feel like a robot. I know I’m doing the right things technically. I know I’m saying the right words, but I say them and I’m talking to families who have a loved one who is dying, and I feel nothing — and I know that something is wrong.’”

    The study compared whether two preparation sessions, followed by a single session using synthesized psilocybin (25 mg dose), followed by three integration sessions reduced participants’ depression symptoms more effectively than the same sequence of sessions with a placebo (niacin, 100 mg). […]

    From participants’ first prep session to 28 days later, psilocybin group members’ depression symptoms declined by an average of 21.33 points, per the rating scale, compared with an average reduction of 9.33 for placebo group members.

    The findings provide evidence, Back said, that guided psilocybin therapy is “dramatically different” than conventional psychotherapy.

    Among the 15 people who got the placebo, depression scores dropped slightly, on average, but the people in the psilocybin group had “much larger drops that were quicker … and were more durable,” he said.

    “I think psilocybin gave them the opportunity to really see their own feelings and see their own situation in a way that they could have more compassion for themselves and more understanding about what had really happened,” Back said. “It was effective because it gave them a new perspective on what they were facing, in a way that they could take action.” […]

    At the time of the study, Rachel Drayer was an emergency department physician assistant in Bellevue, near Seattle. It was work that left her feeling frantic and discordant, she said.

    “(In) the work that I do now, my body feels calm and quiet. It feels … deeply peaceful,” said Drayer, who today lives in rural Wenatchee, Washington, and operates a preventive-health clinic for menopause. “This study changed my life.” […]

    AAAS Public Science News Release: Psilocybin therapy helps clinicians process COVID despair–In a novel study of front-line providers, the psychedelic drug reduced symptoms of depression more effectively than a placebo

    JAMA Network Open: Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic–A Randomized Clinical Trial

    Authors: Anthony L. Back, MD; Timara K. Freeman-Young, PA-C; Ladybird Morgan, MSW; Tanmeet Sethi, MD; Kelsey K. Baker, MS; Susanna Myers, ARNP; Bonnie A. McGregor, PhD; Kalin Harvey, BA; Marlene Tai, MD; Austin Kollefrath, MD; Brandon J. Thomas, MD; Dennis Sorta, MD; Mendel Kaelen, PhD; Benjamin Kelmendi, MD; Ted A. Gooley, PhD.

Leave a Reply

Your email address will not be published. Required fields are marked *